Category: Public Health

Trump has officially begun to withdrawal the US from the World Health Organization as pandemic spikes

Leave a comment

The Trump administration has officially begun to withdraw the United States from the World Health Organization, even as the COVID-19 pandemic continues to grip the globe and infections spike in many states across the U.S.  

Congress received formal notification of the decision on Tuesday, more than a month after President Donald Trump announced his intention to end the U.S. relationship with the WHO and blasted the multilateral institution as a tool of China. The White House said the withdrawal would take effect on July 6, 2021.

Democrats said the decision was irresponsible and ill-considered, noting it comes as the pandemic is raging and international cooperation is vital to confront the crisis.

“This won’t protect American lives or interests – it leaves Americans sick & America alone,” Sen. Bob Menendez, the top Democrat on the Senate Foreign Affairs Committee, tweeted after receiving the White House’s notification. “To call Trump’s response to COVID chaotic & incoherent doesn’t do it justice.”

Tarik Jasarevic, a spokesman for the WHO, said the organization had received reports of the United States’ formal notification. “We have no further information on this at this stage,” he said. 

The formal withdrawal comes as the United States nears 3 million reported coronavirus cases and more than 130,000 deaths, according to Johns Hopkins University data. Globally, there have been 11.6 million cases and almost 540,000 deaths.

Trump and his advisers have blasted the WHO for failing to press China to be more transparent about the scope and severity of the COVID-19 outbreak, which began in Wuhan, China.

Trump has said that China “has total control” over the WHO, even though it contributes far less than the US to the health organization’s budget. The U.S. has contributed approximately $450 million dollars a year.

Menendez and other Senate Democrats have introduced legislation to reverse the decision and restore U.S. funding to the WHO. It’s unclear how far that could get in the GOP-controlled chamber, although some Republicans have also expressed concern with Trump’s decision.

Critics said Trump’s WHO attacks are an attempt to deflect blame from his own mishandling of the coronavirus outbreak – and one that will end up hurting the U.S. 

Amanda Glassman, a public health expert and executive vice president of the Center for Global Development think tank, noted the world doesn’t just face today’s threat of COVID-19 but also the treat of future pandemics, which are more likely because of increased zoonotic transmission. 

The probability of a high lethality strain of influenza in the next decade or so is also significant, said Amanda Glassman, a public health expert and executive vice president of the Center for Global Development think tank. She said corrective measures at the WHO are needed but can only happen with the United States staying engaged.

“Withdrawal is counterintuitive at best and dangerous to human life at worst. The US Congress should immediately explore what power it has to prevent this from happening,” Glassman said

Gayle Smith, president and CEO of The ONE Campaign, an advocacy group focused on improving global health and eliminating poverty, echoed that assessment. “The US should use its influence to strengthen and reform the WHO, not abandon it at a time when the world needs it most,” said Smith, who served on the National Security Council and other top positions in the Obama administration.

[USA Today]

Trump says the U.S. will cut ties with World Health Organization

Leave a comment

President Donald Trump announced Friday that the United States will cut ties with the World Health Organization.

“China has total control over the World Health Organization despite only paying $40 million per year compared to what the United States has been paying, which is approximately $450 million a year,” Trump said during a news conference in the White House Rose Garden.

“The world needs answers from China on the virus. We must have transparency. Why is it that China shut off infected people from Wuhan to all other parts of China?” he added. “It didn’t go to Beijing, it went nowhere else, but they allowed them to freely travel throughout the world, including Europe and the United States.”

Trump has repeatedly criticized the WHO’s response to the coronavirus, which has hit the U.S. worse than any other country, amid scrutiny of his own administration’s response to the pandemic. He has claimed the WHO is “China-centric” and blames the agency for advising against China travel bans early in the outbreak. 

“Fortunately, I was not convinced and suspended travel from China saving untold numbers of lives,” Trump said April 14. 

The agency has defended its initial response to the coronavirus pandemic, saying it gave world leaders enough time to intervene early in the outbreak.

The agency declared Covid-19 a global health emergency on Jan. 30 when there were only 82 cases outside of China and zero deaths, WHO Director-General Tedros Adhanom Ghebreyesus said during a press conference on May 1. “Meaning, the world had enough time to intervene.”

The WHO has also defended China, saying as far back as February that the country’s response to the virus was an improvement from past outbreaks such as SARS.

Earlier this month, Trump threatened to permanently cut off U.S. funding of the WHO. In a letter, he said that if the WHO “does not commit to major substantive improvements within the next 30 days, I will make my temporary freeze of United States funding to the World Health Organization permanent and reconsider our membership in the organization.”

On Friday, Trump said the WHO “failed to make the requested greatly needed reform” and the U.S. “will be today terminating our relationship with the World Health Organization and redirecting those funds to other worldwide and deserving urgent global public health needs.”

The WHO’s funding runs in two-year budget cycles. For the 2018 and 2019 funding cycle, the U.S. paid a $237 million required assessment as well as $656 million in voluntary contributions, averaging $446 million a year and representing about 14.67% of its total budget, according to WHO spokesman Tarik Jasarevic. 

It’s unclear exactly what mechanism Trump intends to use to terminate WHO funding, much of which is appropriated by Congress. The president typically does not have the authority to unilaterally redirect congressional funding.

Lawrence Gostin, a professor and faculty director of the O’Neill Institute for National and Global Health Law at Georgetown University, said in a tweet Friday that Trump’s move is “unlawful” because pulling funding requires Congress, which has already authorized funding.

It’s also “dangerous” because “we’re in the middle of a pandemic,” he said.

On May 20, WHO officials said they worried the agency’s emergency programs would suffer if the president permanently pulled U.S. funding from the international agency.

Most funding from the United States goes directly out to the program that helps countries in “all sorts of fragile and difficult settings,” Dr. Mike Ryan, executive director of WHO’s health emergencies program, said at the time. 

“We’ll obviously have to work with other partners to ensure those funds can still flow,” Ryan said. “This is going to be a major implication for delivering essential health services to some of the most vulnerable people in the world, and we trust developed donors will, if necessary, step in to fill that gap.”

The WHO started sounding the alarm on the outbreak in China in mid-January. On March 11, WHO officials declared the outbreak a pandemic, when there were just 121,000 global cases. The virus has now infected more than 5.8 million people worldwide, including more than 1.73 million in the U.S., according to data compiled by Johns Hopkins University. 

[NBC News]

Trump halts US funding for World Health Organization as it conducts coronavirus review

Leave a comment

The U.S. will suspend funding to the World Health Organization while it reviews the agency’s response to the Covid-19 pandemic, President Donald Trump announced Tuesday, saying the international health agency made mistakes that “caused so much death” as the coronavirus spread across the globe.

“Today I’m instructing my administration to halt funding of the World Health Organization while a review is conducted to assess the World Health Organization’s role in severely mismanaging and covering up the spread of the coronavirus,” Trump said at a White House press conference.

Trump criticized the international agency’s response to the outbreak, saying “one of the most dangerous and costly decisions from the WHO was its disastrous decision to oppose travel restrictions from China and other nations” that Trump imposed early on in the outbreak.

“Fortunately, I was not convinced and suspended travel from China saving untold numbers of lives,” he said.

It’s unclear exactly what mechanism Trump intends to use to withhold WHO funding, much of which is appropriated by Congress. The president typically does not have the authority to unilaterally redirect congressional funding.

One option might be for Trump to use powers granted to the president under the Impoundment Control Act of 1974. Under this statute, the president may propose to withhold congressional funds, but it requires congressional approval within 45 days. Absent this approval, the funds must be returned to their original, congressionally mandated purpose after 45 days.

When asked by reporters why the administration is choosing now to withhold funds, Trump said the U.S. has had problems with WHO “for years” and the nation should have done this “a long time ago.”

He said the administration will conduct a “thorough” investigation that should last 60 to 90 days.

Trump said it wasn’t about the money, “but it’s not right. So we’ll see,” he said. “This is an evaluation period, but in the meantime, we’re putting a hold on all funds going to World Health. We’ll be able to take that money and channel it to the areas that most need it.” 

The WHO didn’t immediately return CNBC’s request for comment. But in a statement, UN Secretary General Antonio Guterres said that now is not the time to reduce resources in the fight against Covid-19.

He said there will come a time after the epidemic is over, to look back and understand how the disease emerged and spread its devastation so quickly, “but now is not that time.”

“It is also not the time to reduce the resources for the operations of the World Health Organization or any other humanitarian organization in the fight against the virus,” Guterres said.

The coronavirus, which emerged in Wuhan, China over three months ago, has infected more than 1.9 million people worldwide and killed at least 125,678 as of Tuesday night, according to data compiled by Johns Hopkins University.

Trump had first threatened last week to withhold funds from WHO, saying it pushed back on his travel ban from China early in the Covid-19 outbreak. He claimed Tuesday that WHO “pushed China’s misinformation about the virus, saying it wasn’t communicable and there was no need for travel bans.”

“The WHO willingly took China’s assurances at face value, and they willingly took it at face value and defended the actions of the Chinese government even while praising China for its so-called transparency,” he said. “I don’t think so.”

WHO started sounding the alarm on the outbreak of a new coronavirus in China, in mid-January, designating the now Covid-19 pandemic as a global health emergency on Jan. 30 when there were just 8,200 cases in 18 countries across the world.

The WHO’s global emergency declaration on Jan. 30 was nearly a month before Trump tweeted that “The Coronavirus is very much under control in the USA” and six weeks before he declared a national emergency on March 13.

Two days earlier, on March 11, WHO officials declared the outbreak a pandemic, when there were just 121,000 global cases. 

In response to Trump’s attacks last week, WHO’s top official urged leaders against politicizing the outbreak “if you don’t want to have many more body bags.”

“At the end of the day, the people belong to all political parties. The focus of all political parties should be to save their people, please do not politicize this virus,”  Director-General Dr. Tedros Adhanom Ghebreyesus said in a fiery address on April 8. He called for unity across the globe, saying the virus will exploit cracks in political parties, religious groups or between different nations to spread even more widely. “If you want to be exploited and if you want to have many more body bags, then you do it. If you don’t want many more body bags, then you refrain from politicizing it,” he said.

[CNBC]


Trump announces U.S. will halt funding for WHO over coronavirus response

Leave a comment

President Trump announced Tuesday that the U.S. is placing a hold on funding to the World Health Organization for 60–90 days over its handling of the coronavirus pandemic, pending a review.

Driving the news: Trump accused the WHO of “severely mismanaging and covering up” the coronavirus crisis, adding that the U.S. “has a duty to insist on full accountability.”

  • “With the outbreak of the COVID-19 pandemic, we have deep concerns whether America’s generosity has been put to the best use possible,” Trump said at a briefing in the Rose Garden.
  • “If we cannot trust them, if this is what we will receive from the WHO, our country will be forced to find other ways to work with other nations to achieve public health goals.” 

By the numbers: The WHO’s 2018–2019 budget was about $6 billion, and the U.S. is by far the biggest donor of any country, contributing more than $400 million to the organization last year.

  • “American taxpayers provided between $400 million and $500 million per year to the WHO. In contrast, China contributes roughly $40 million a year, or even less,” Trump said Tuesday.
  • “As the organization’s leading sponsor, the United States has a duty to insist on full accountability. One of the most dangerous and costly decisions from the WHO was its disastrous decision to oppose travel restrictions from China and other nations.”

Behind the scenes: Trump has been fuming for days about what he sees as the WHO’s botched response to the pandemic and its deference to China.

  • “The W.H.O. really blew it. For some reason, funded largely by the United States, yet very China centric. We will be giving that a good look,” Trump tweeted last week.
  • Trump’s national security team has rallied behind him, believing that the U.S. needed to go beyond public statements and make the WHO feel some pain for its missteps, according to officials involved in the internal discussions.
  • Our thought bubble: The decision gives Trump somebody else to blame and a way to deflect from his own missteps in handling the virus.

Details: Below are some of Trump’s specific complaints, which he said led him to his decision to freeze U.S. funding:

  • “The WHO failed to adequately obtain, vet and share information in a timely and transparent fashion. … The WHO failed in this basic duty and must be held accountable.”
  • “The WHO failed to investigate credible reports from sources in Wuhan that conflicted directly with the Chinese government’s official accounts. There was credible information to suspect human-to-human transmission in December 2019, which should have spurred the WHO to investigate.”
  • “Through the middle of January, it parroted and publicly endorsed the idea that there was not human-to-human transmission happening, despite reports and clear evidence to the contrary. “
  • “The delays the WHO experienced in declaring a public health emergency cost valuable time, tremendous amounts of time.”
  • “The inability of the WHO to obtain virus samples to this day has deprived the scientific community of essential data.”
  • “The WHO has not addressed a single one of these concerns nor provided a serious explanation that acknowledges its own mistakes, of which there were many.”

Background: Over the past week, officials within the White House’s Office of Management and Budget have been working on a menu of options for how to snub the WHO. Trump administration officials told Axios the options fall along two tracks.

  • The most likely route is to reprogram U.S. funding that was allocated to the WHO, moving it to other international organizations that can administer it for comparable purposes, officials said.
  • A more dramatic, but less likely, approach is to send a rescissions package to Congress, rescinding from the federal budget funds already allocated to WHO. A similar approach was adopted in 2017 when the U.S. cut $285 million from its funding to the United Nations.
  • Trump did not reveal on Tuesday which mechanism he will use to halt funding to the organization.

What they’re saying: António Guterres, secretary-general of the UN, to which the WHO reports, said in a statement, “Now is a time for unity in the global battle to push the COVID-19 pandemic into reverse, not a time to cut the resources of the … WHO, which is spearheading and coordinating the global body’s efforts.”

[Axios]

Inside the epic White House fight over hydroxychloroquine

Leave a comment

The White House coronavirus task force had its biggest fight yeton Saturday, pitting economic adviser Peter Navarro against infectious disease expert Anthony Fauci. At issue: How enthusiastically should the White House tout the prospects of an antimalarial drug to fight COVID-19?

Behind the scenes: This drama erupted into an epic Situation Room showdown. Trump’s coronavirus task force gathered in the White House Situation Room on Saturday at about 1:30pm, according to four sources familiar with the conversation. Vice President Mike Pence sat at the head of the table.

  • Numerous government officials were at the table, including Fauci, coronavirus response coordinator Deborah Birx, Jared Kushner, acting Homeland Security Secretary Chad Wolf, and Commissioner of Food and Drugs Stephen Hahn.
  • Behind them sat staff, including Peter Navarro, tapped by Trump to compel private companies to meet the government’s coronavirus needs under the Defense Production Act.

Toward the end of the meeting, Hahn began a discussion of the malaria drug hydroxychloroquine, which Trump believes could be a “game-changer” against the coronavirus.

  • Hahn gave an update about the drug and what he was seeing in different trials and real-world results.
  • Then Navarro got up. He brought over a stack of folders and dropped them on the table. People started passing them around.
  • “And the first words out of his mouth are that the studies that he’s seen, I believe they’re mostly overseas, show ‘clear therapeutic efficacy,'” said a source familiar with the conversation. “Those are the exact words out of his mouth.”

Navarro’s comments set off a heated exchange about how the Trump administration and the president ought to talk about the malaria drug, which Fauci and other public health officials stress is unproven to combat COVID-19.

  • Fauci pushed back against Navarro, saying that there was only anecdotal evidence that hydroxychloroquine works against the coronavirus.
  • Researchers have said studies out of France and China are inadequate because they did not include control groups.
  • Fauci and others have said much more data is needed to prove that hydroxychloroquine is effective against the coronavirus.
  • As part of his role, Navarro has been trying to source hydroxychloroquine from around the world. He’s also been trying to ensure that there are enough domestic production capabilities inside the U.S.

Fauci’s mention of anecdotal evidence “just set Peter off,” said one of the sources. Navarro pointed to the pile of folders on the desk, which included printouts of studies on hydroxychloroquine from around the world.

  • Navarro said to Fauci, “That’s science, not anecdote,” said another of the sources.

Navarro started raising his voice, and at one point accused Fauci of objecting to Trump’s travel restrictions, saying, “You were the one who early on objected to the travel restrictions with China,” saying that travel restrictions don’t work. (Navarro was one of the earliest to push the China travel ban.)

  • Fauci looked confused, according to a source in the room. After Trump imposed the travel restrictions, Fauci has publicly praised the president’s restriction on travel from China.
  • Pence was trying to moderate the heated discussion. “It was pretty clear that everyone was just trying to get Peter to sit down and stop being so confrontational,” said one of the sources.
  • Eventually, Kushner turned to Navarro and said, “Peter, take yes for an answer,” because most everyone agreed, by that time, it was important to surge the supply of the drug to hot zones.
  • The principals agreed that the administration’s public stance should be that the decision to use the drug is between doctors and patients.
  • Trump ended up announcing at his press conference that he had 29 million doses of hydroxychloroquine in the Strategic National Stockpile.

Between the lines: “There has never been a confrontation in the task force meetings like the one yesterday,” said a source familiar with the argument. “People speak up and there’s robust debate, but there’s never been a confrontation. Yesterday was the first confrontation.”

  • In response to a request for comment on Axios’ reporting, Katie Miller, a spokesperson for the vice president, said: “We don’t comment on meetings in the Situation Room.”

The bottom line: The way to discuss the drug’s potential has become a fraught issue within the Trump administration.

  • Most members of the task force support a cautious approach to discussing the drug until it’s proven.
  • Navarro, on the other hand, is convinced based on his reading that the drug works against the coronavirus and speaks about it enthusiastically.
  • Some of Trump’s favorite TV hosts, including Fox’s Sean Hannity, and friends including Rudy Giuliani, have also been touting the malaria drug for the coronavirus. Trump has made no secret who he sides with.
  • “What do you have to lose? Take it,” the president said in a White House briefing on Saturday. “I really think they should take it. But it’s their choice. And it’s their doctor’s choice or the doctors in the hospital. But hydroxychloroquine. Try it, if you’d like.”

[Axios]

EPA suspends enforcement of environmental laws amid coronavirus

Leave a comment

The Environmental Protection Agency (EPA) issued a sweeping suspension of its enforcement of environmental laws Thursday, telling companies they would not need to meet environmental standards during the coronavirus outbreak.  

The temporary policy, for which the EPA has set no end date, would allow any number of industries to skirt environmental laws, with the agency saying it will not “seek penalties for noncompliance with routine monitoring and reporting obligations.”

Cynthia Giles, who headed the EPA’s Office of Enforcement during the Obama administration, called it a moratorium on enforcing the nation’s environmental laws and an abdication of the agency’s duty. 

“This EPA statement is essentially a nationwide waiver of environmental rules for the indefinite future. It tells companies across the country that they will not face enforcement even if they emit unlawful air and water pollution in violation of environmental laws, so long as they claim that those failures are in some way ’caused’ by the virus pandemic. And it allows them an out on monitoring too, so we may never know how bad the violating pollution was,” she wrote in a statement to The Hill.

The EPA has been under pressure from a number of industries, including the oil industry, to suspend enforcement of a number of environmental regulations due to the pandemic.

“EPA is committed to protecting human health and the environment, but recognizes challenges resulting from efforts to protect workers and the public from COVID-19 may directly impact the ability of regulated facilities to meet all federal regulatory requirements,” EPA Administrator Andrew Wheeler said in a statement. 

In a 10-page letter to the EPA earlier this week, the American Petroleum Institute (API) asked for a suspension of rules that require repairing leaky equipment as well as monitoring to make sure pollution doesn’t seep into nearby water.

Other industries had also asked to ignite the “force majeure” clauses of any legal settlements they had signed with the EPA, allowing for an extension on deadlines to meet various environmental goals in the face of unforeseen circumstances.

But Giles and others say the memo signed Thursday goes beyond that request, giving industries board authority to pollute with little oversight from the agency. 

“Incredibly, the EPA statement does not even reserve EPA’s right to act in the event of an imminent threat to public health,” Giles said. 

“Instead, EPA says it will defer to states, and ‘work with the facility’ to minimize or prevent the threat. EPA should never relinquish its right and its obligation to act immediately and decisively when there is threat to public health, no matter what the reason is. I am not aware of any instance when EPA ever relinquished this fundamental authority as it does in this memo.”

The memo says companies should try to minimize “the effects and duration of any noncompliance” with environmental laws and should also keep records of their own noncompliance, along with identifying how the coronavirus was a factor.The EPA on Friday pushed back against characterization of the memo as a waiver of environmental rules. “During this extraordinary time, EPA believes that it is more important for facilities to ensure that their pollution control equipment remains up and running and the facilities are operating safely, than to carry out routine sampling and reporting,” agency spokeswoman Andrea Woods told The Hill by email. “If a facility has exceedances of limits on pollution the policy does not offer any no action assurance. We retain all our authorities and will exercise them appropriately. It is a temporary policy and will be terminated when this crisis is past.”

Critics say it’s not unreasonable to refrain from environmental enforcement on a case-by-case basis when companies are unable to comply with the letter of the law, but many were alarmed by the breadth of Thursdays memo.

“It is not clear why refineries, chemical plants, and other facilities that continue to operate and keep their employees on the production line will no longer have the staff or time they need to comply with environmental laws,” Eric Schaeffer, a former director of civil enforcement at the EPA who is now with the Environmental Integrity Project, wrote in a letter signed by a number of environmental groups in anticipation of the memo.

The letter writers also criticized the requests from the API, arguing nearby communities would face prolonged exposure to a number of air and water pollutants that might be expelled through oil production — something they say would have “a very specific impact on public health and safety.”

The diminished compliance requirements for industry comes at a time when the EPA has refused to budge on deadlines for comments as they proceed with a number of deregulatory actions.

Environmental and public health groups had argued that those with science and health backgrounds who would normally weigh in on such regulations have been pulled into the coronavirus fight, leaving them unable to divert their attention.

“The Environmental Protection Agency has not shown the same concern for the impact the coronavirus has had on the ability of community and public interest groups to respond to various proposals to weaken environmental standards,” Schaeffer wrote in the letter.

But the EPA has argued exceptions were not needed.

“We’re open and continuing our regulatory work business as usual,” an EPA spokesperson told The Hill in a statement. “As regulations.gov is fully functioning, there is no barrier to the public providing comment during the established periods.”

[The Hill]

Trump falsely claims drug approval for virus

Leave a comment

President Donald Trump misstated the facts Thursday when he asserted that the Food and Drug Administration had just approved a decades-old malaria drug to treat patients infected by the coronavirus. After his FDA chief clarified that the drug still needs testing, Trump also overstated the drug’s potential upside in helping contain the outbreak.

A look at his claims at a news briefing:

TRUMP: “And we’re going to be able to make that drug available almost immediately, and that’s where the FDA has been so great. They — they’ve gone through the approval process. It’s been approved.”

THE FACTS: The drug, known chemically as chloroquine, has been available for decades to treat the mosquito-borne illness malaria. Technically, doctors can already prescribe the drug to patients with COVID-19, a practice known as off-label prescribing. But Trump falsely suggested to reporters that the FDA had just cleared the drug specifically for the viral pandemic spreading in communities across the U.S. That would mean that the drug had met the FDA’s standards for safety and effectiveness.

Minutes later, FDA Commissioner Dr. Stephen Hahn emphasized that the drug still needs testing to determine if it can help patients. He said chloroquine would have to be tested in “a large pragmatic clinical trial to actually gather that information.”

Drug trials typically require hundreds or thousands of patients and, even when accelerated, take weeks or months to complete. In his remarks, Hahn reflected on his background as a cancer doctor and warned against giving patients “false hope” before drugs are fully vetted.

While chloroquine has shown promise in preliminary laboratory studies, some experts are skeptical it will prove effective in human testing.

“I think it could be a game changer, and maybe not,” Trump said, discussing the drug.

But the FDA reiterated in a statement Thursday that there are “no FDA-approved therapeutics or drugs to treat, cure or prevent COVID-19.”

___

TRUMP: “If chloroquine or hydroxychloroquine works, or any of the other things that they’re looking at that are not quite as far out … your numbers are going to come down very rapidly.”

THE FACTS: The drugs he is referring to are for treatment in patients already infected. That doesn’t prevent spread of the virus. One study is testing chloroquine to try to protect health care workers at highest risk of infection, because a vaccine is likely a year or more away.

[Associated Press]

Trump Offered ‘Large Sum’ to German Company for Exclusive Access to Coronavirus Vaccine Research

Leave a comment

The Trump administration attempted to persuade a German firm developing a possible vaccine for coronavirus to move its research work to the United States, German officials said, raising fears in Berlin that President Trump was trying to assure that any inoculation would be available first, and perhaps exclusively, in the United States.

The offer arose from a March 2 meeting at the White House that included the chief executive of the German firm CureVac, Daniel Menichella. President Trump briefly attended the meeting and Vice President Mike Pence, who heads the White House coronavirus task force, was also there.

“We are very confident that we will be able to develop a potent vaccine candidate within a few months,” Mr. Menichella said in a statement on the day of the meeting.

But four days ago, CureVac announced that Mr. Menichella, an American, was leaving the biotechnology company, which he had headed for two years.

The announcement gave no reason for his sudden departure and said one of the firm’s founders, Ingmar Hoerr, would succeed him. It thanked Mr. Menichella for a variety of accomplishments, including “the recent start of our coronavirus vaccine program.”

On Sunday, the company issued a statement in Germany describing its vaccine work. “CureVac refrains from commenting on current media speculations and clearly rejects claims about the sale of the company or its technology,” it said.

White House officials did not immediately respond to requests for comment. But two senior American officials said that some of the German news accounts first reporting the story were overblown, particularly with regard to any effort by the United States to secure exclusive access to a vaccine.

The Trump administration has spoken with more than 25 companies that say they can help with a vaccine, one of the American officials said, and is open to speaking with others. Any solution, he said, would be shared with the world.

Nevertheless, Germany’s interior minister, Horst Seehofer, said that Chancellor Angela Merkel, who has a famously testy relationship with Mr. Trump, will lead a crisis meeting with ministers on Monday that will include discussion of a German defense strategy for the firm.

The coronavirus is no longer merely a health crisis, but “a question of national security,” Mr. Seehofer said Sunday. It is up to the government, he said, to ensure not only security of its borders and its food supply, but also “our medical products and our medicines.”

Asked by a reporter to confirm that the U.S. administration had tried to take over a German company researching vaccines, Mr. Seehofer responded that he had heard about the effort “from several members of the government and it will be discussed tomorrow in the crisis team.”

Another official, who asked not to be identified because he is not authorized to speak to the media, said the company was offered a “large sum” of money.

The privately held biotechnology firm has its headquarters in the southwestern city of Tübingen, Germany. It also has an office in Boston, where many of the nation’s leading biotech firms have operations around the Harvard and Massachusetts Institute of Technology campuses.

According to the German newspaper Die Welt am Sonntag, which first reported the story on Sunday, Mr. Trump offered CureVac roughly $1 billion in exchange for exclusive access to the vaccine. The newspaper quoted an unnamed German government source who said Mr. Trump wanted the resulting vaccine “only for the United States.”

But another German official, reached by The New York Times, said it was unclear whether the administration simply wanted the research work, and for any resulting production to be on American soil.

Mr. Menichella was one of several industry executives invited by the White House to meet Mr. Pence, members of the coronavirus task force and pharmaceutical executives and discuss strategies to quickly develop a vaccine, the company said on its website.

CureVac started research on a number of different vaccines and is now picking the two best prospects for clinical trials, the firm’s website indicates. The company hopes that by June or July it will have an experimental vaccine that could go into trials. Many other companies are also working on vaccines.

The Trump administration has been unusually aggressive in attempting to get American control of companies that deal in technology Mr. Trump views as central to American security.

In February, Attorney General William P. Barr suggested in a speech that the United States should find a way to take over two European telecommunications makers, Ericsson and Nokia, which are the main competitors of Huawei, the Chinese telecommunications giant that is wiring up nations around the world for 5G, or fifth generation, networks.

Mr. Pence later played down that suggestion. But the idea that the Trump administration was seeking to take control of a major European technological asset sent unsettling ripples across Europe.

And the move to secure the intellectual property of CureVac, whether for exclusive or general use, is bound to inflame that debate.

Die Welt reported that the German government was making counterbids to the company to persuade it to stay. German lawmakers began to issue statements on Sunday.

“The exclusive sale of a possible vaccine to the USA must be prevented by all means,” Karl Lauterbach, a German lawmaker who is also a professor of epidemiology, said on Twitter. “Capitalism has limits.”

Adding to the dismay in Germany was the fact that CureVac works closely with a taxpayer-funded government research organization, the Paul Ehrlich Institute for vaccines and biomedicines.

Peter Altmaier, Germany’s economy minister, praised the company for not being tempted by any American offer. “It was a great decision,” he said in a television talk show on Sunday night. “Germany is not for sale.”

Mr. Altmaier said the government would “make sure that the necessary help is available” to the company in developing the vaccine. And he warned that if any hostile offer was attempted, Germany would step in.

“When it’s about important infrastructure and national and European interest,” he said, “we will also act if we have to.”

CureVac’s main investor ruled out giving exclusive access to a future vaccine to one country.

“We want to develop a vaccine for the whole world, and not for individual states,” Christof Hettich, chief executive of Dievini Hopp Biotech Holding, told the newspaper Mannheimer Morgen.

German officials sounded unsure about the reassurances that the United States would share a vaccine if it were developed.

A spokesman for the German health ministry said that German government officials were in regular contact with CureVac, confirming a quote in the original Die Welt article.

“The federal government is very interested in vaccines and antiviral agents against the novel coronavirus being developed in Germany and Europe,” the spokesman was quoted as saying in the original article. “In this regard the government is in an intensive exchange with the company CureVac.”

[The New York Times]

Trump Snaps at ‘Nasty Question’ About Disbanding White House Pandemic Office in 2018

Leave a comment

President Donald Trump snapped at a reporter’s “nasty question” about his administration decimating the White House pandemic department in 2018.

PBS News reporter Yamiche Alcindor asked Trump on Friday during a coronavirus press conference about his claim he takes no responsibility for problems with the response to the pandemic.

“My first question is you said that you don’t take responsibility but you did disband the White House pandemic office and the officials that were working in that office left this administration abruptly. So what responsibility do you take to that?” asked the PBS NewsHour reporter. “The officials that worked in that office said that the White House lost valuable time because that office was disbanded. What do you make of that?”

“Well, I just think it’s a nasty question because what we’ve done, and Tony [Fauci] had said numerous times that we saved thousands of lives because of the quick closing,” President Trump responded. “And when you say me, I didn’t do it. We have a group of people… I could have perhaps ask Tony about that because I don’t know anything about it. I mean you say we did that, I don’t know anything about it. It’s the administration, perhaps, they do that. You know people let people go.”

“You used to be with a different newspaper than you are now, you know things like that happen,” he continued, before adding, “We are doing a great job. Let me tell you, these professionals behind me and these great incredible doctors and business people, the best in the world, and I can say that whether it’s retailers or labs or anything you want to say.”

“These are the best in the world,” President Trump concluded. “We are doing a great job.”

[Mediaite]

Media

Trump calls coronavirus a ‘foreign virus’ in Oval Office address

Leave a comment

President Donald Trump referred to the novel coronavirus as a “foreign virus” in his Oval Office address on Wednesday night.

The characterization of the global pandemic as a foreign virus aligns with how some Trump allies have described the coronavirus in recent days, which critics have called xenophobic.

“This is the most aggressive and comprehensive effort to confront a foreign virus in modern history,” the President said.

“I am confident that by counting and continuing to take these tough measures we will significantly reduce the threat to our citizens and we will ultimately and expeditiously defeat this virus.”

The rare Oval Office address to the nation by Trump came as his administration has faced harsh criticism for his response to the pandemic. The President said he was “marshaling the full power of the federal government” to confront the growing public health crisis, including a monthlong halt in travel from Europe to the United States.

The address came the same day the World Health Organization declared the virus a pandemic, with more than 1,200 cases in the US.

The outbreak has not just sparked fear and anxiety in countries like the US and the UK — it has also seen a rise in xenophobic and racist assaults against people of East Asian, and particularly Chinese, descent. And panic over the virus continues to pummel the Chinese business sector in cities like New York, where fear of the disease has driven people away from east Asian neighborhoods.

The President’s reference to the virus as “foreign” echoes a tweet he shared earlier this week promoting a US southern-border wall as a way to protect Americans from the “China Virus.”

Trump, adding his own comment to the tweet, said, “Going up fast. We need the Wall more than ever!”
The post was met with fierce pushback from critics, including Democratic presidential front-runner Joe Biden, who tweeted, “A wall won’t stop a virus. Racism won’t stop a virus.

“Do your job.”

[CNN]

Reality

Donald Trump referred to the novel coronavirus as a “foreign virus” in his Oval Office address on Wednesday night, echoing Fox News and Republicans who have sought to frame the Chinese people as “bat eaters” from an “uncivilized world.”

The White House had to issue a correction after Trump was unable to read directly from a teleprompter and announced he is banning goods trade from Europe although he is not banning goods trade from Europe.

“And these prohibitions will not only apply to the tremendous amount of trade and cargo but various other things as we get approval,” Trump said. “Anything coming from Europe to the United States is what we are discussing.”

The White House quickly noted that the restrictions were focused on people, not boxes, and Trump later appeared to clarify his remarks in a tweet.

Media

1 2 3 … 6